Sepideh Barzin Tond

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Magnetic Resonance

Long Noncoding Rna

Top Venues

DNA and cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Sahar Yarahmadi, Navid Farahmandian, Reza Fadaei, Mehdi Koushki, Elham Bahreini, Saeed Karima, Sepideh Barzin Tond, Azadeh Rezaei, Mitra Nourbakhsh, Soudabeh Fallah
Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33. DNA and cell biology 42 (2) (2023)
Sahar Yarahmadi, Navid Farahmandian, Reza Fadaei, Mehdi Koushki, Elham Bahreini, Saeed Karima, Sepideh Barzin Tond, Azadeh Rezaei, Mitra Nourbakhsh, Soudabeh Fallah
Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33. DNA and cell biology 42 (2) (2023)
Sahar Yarahmadi, Navid Farahmandian, Reza Fadaei, Mehdi Koushki, Elham Bahreini, Saeed Karima, Sepideh Barzin Tond, Azadeh Rezaei, Mitra Nourbakhsh, Soudabeh Fallah
Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33. DNA and cell biology (2023)
Sahar Yarahmadi, Navid Farahmandian, Reza Fadaei, Mehdi Koushki, Elham Bahreini, Saeed Karima, Sepideh Barzin Tond, Azadeh Rezaei, Mitra Nourbakhsh, Soudabeh Fallah
Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33. DNA and cell biology 42 (2) (2023)